BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17924993)

  • 1. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.
    Reams BD; Musselwhite LW; Zaas DW; Steele MP; Garantziotis S; Eu PC; Snyder LD; Curl J; Lin SS; Davis RD; Palmer SM
    Am J Transplant; 2007 Dec; 7(12):2802-8. PubMed ID: 17924993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
    Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
    Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year outcomes with alemtuzumab induction after lung transplantation.
    Shyu S; Dew MA; Pilewski JM; DeVito Dabbs AJ; Zaldonis DB; Studer SM; Crespo MM; Toyoda Y; Bermudez CA; McCurry KR
    J Heart Lung Transplant; 2011 Jul; 30(7):743-54. PubMed ID: 21420318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory acute rejection in a lung transplant recipient with campath 1H.
    Reams BD; Davis RD; Curl J; Palmer SM
    Transplantation; 2002 Sep; 74(6):903-4. PubMed ID: 12364881
    [No Abstract]   [Full Text] [Related]  

  • 6. Alemtuzumab induction in renal transplantation.
    Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
    N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
    PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
    Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
    Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
    Gómez-Almaguer D; Ruiz-Argüelles GJ; del Carmen Tarín-Arzaga L; González-Llano O; Gutiérrez-Aguirre H; Cantú-Rodríguez O; Jaime-Pérez J; Carrasco-Yalán A; Giralt S
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):10-5. PubMed ID: 18158956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
    Hayes D; Black SM; Tobias JD; Kopp BT; Kirkby SE; Mansour HM; Whitson BA
    J Heart Lung Transplant; 2016 Feb; 35(2):186-94. PubMed ID: 26496787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
    Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.